Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Israel, Bahrain leaders discuss Iran, possible vaccine plant

Published 02/25/2021, 05:00 AM
Updated 02/25/2021, 06:30 AM
© Reuters. FILE PHOTO: Bahrain's Crown Prince Sheikh Salman bin Hamad al Khalifa attends the opening session of the 25th Arab League Summit in Bayan Palace

JERUSALEM (Reuters) - Israeli Prime Minister Benjamin Netanyahu and Bahrain's Crown Prince Sheikh Salman bin Hamad Al Khalifa on Thursday discussed Iran and the possible involvement of the Gulf state in establishing a vaccine plant in Israel, the two countries said.

Bahrain and the United Arab Emirates formalised ties with Israel on Sept. 15 in part over shared concerns about Iran, in a deal forged by former U.S. President Donald Trump.

Trump withdrew from a 2015 nuclear deal between Tehran and world powers, a move praised by Israel which has objected to the accord. His successor, President Joe Biden, wants to rejoin the deal.

But in the week since Washington offered to talk with Tehran about reviving the nuclear deal, Iran has curbed U.N. monitoring and threatened to boost its uranium enrichment. Tehran denies it is seeking nuclear weapons.

An Israeli official said on Tuesday that Israel hopes to prevent personal tension between Netanyahu, who is seeking re-election on March 23, and Biden over their differences on Iran policy by delegating talks on the topic to their senior staff.

Netanyahu and Khalifa both released statements about their telephone call on Thursday but only the Bahraini announcement mentioned Iran.

Their conversation stressed the importance for the "countries of the region to take part in any talks about Iran's nuclear file," the kingdom's state media office said on Twitter.

Netanyahu's office said he spoke with Khalifa about visiting Bahrain once coronavirus restrictions would allow it.

"The Bahraini regent also stated that he was interested in examining the possibility of Bahrain joining an investment in a vaccine manufacturing plant that is planned to be established in Israel together with other countries," the statement said.

Netanyahu said on Wednesday he was in talks with the heads of Pfizer (NYSE:PFE) and Moderna (NASDAQ:MRNA) to open facilities in Israel. Neither company responded to Reuters requests for comment.

Israel has been importing Pfizer-BioNTech and Moderna Inc COVID-19 vaccines.

© Reuters. FILE PHOTO: Israeli Prime Minister Benjamin Netanyahu meets the 4,000,000 person vaccinated in Israel

Israel expects trade with Bahrain to be around $220 million in 2021, not including possible defence and tourism deals.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.